Mark P. Colonnese
Overview
Mark P. Colonnese received an average of $666K in total compensation, including $209K in salary, at Biota Pharmaceuticals from 2016 to 2018. Mark Colonnese also received $296K at Transgenomic in 2012.
- 2018
- 2017
- 2016
- 2012
Biota PharmaceuticalsFormer Executive Vice President and Chief Financial Officer
Biota PharmaceuticalsFormer Executive Vice President and Chief Financial Officer
Biota PharmaceuticalsExecutive Vice President and Chief Financial Officer
TransgenomicExecutive Vice President and Chief Financial Officer
Source: SEC filings on March 11, 2019, February 26, 2018, September 27, 2016, and April 25, 2013.
Related executives
We found 28 more executives who work or worked at Biota Pharmaceuticals and Transgenomic.
Andrei Floroiu
Biota Pharmaceuticals
Chief Executive Officer
James Cummings
Biota Pharmaceuticals
Chief Medical Officer
Sean Tucker
Biota Pharmaceuticals
Chief Scientific Officer
Ilan Danieli
Transgenomic
Chief Executive Officer
Carl Iberger
Transgenomic
Chief Financial Officer
Ayman Mohamed
Transgenomic
VP R&D
Ahmed Sabet
Transgenomic
Chief Operations Officer
Wouter Latour
Biota Pharmaceuticals